Global Yellow Fever Vaccines Market Strategic Research Report

Scope of the Report

The global Yellow Fever Vaccines market size is predicted to grow from US$ 149 million in 2025 to US$ 197 million in 2032; it is expected to grow at a CAGR of 4.1% from 2026 to 2032.

Yellow fever vaccine is a vaccine that can prevent yellow fever. The vaccination targets are people who enter or pass through the epidemic area.

The global Yellow Fever Vaccines market is primarily driven by the increasing risk of yellow fever outbreaks, particularly in endemic regions such as sub-Saharan Africa and parts of South America. Growing international travel and global mobility have heightened the need for preventive vaccination, especially in travelers visiting high-risk areas. Government-led immunization programs and World Health Organization (WHO) initiatives, such as the Eliminate Yellow Fever Epidemics (EYE) strategy, also contribute to increased vaccine demand. Moreover, rising public health awareness and emergency stockpiling by international health agencies are enhancing market growth, with mass vaccination campaigns being conducted to prevent potential epidemics.

Despite the demand, the Yellow Fever Vaccines market faces several significant challenges. Limited global manufacturing capacity can lead to supply shortages during epidemic surges, causing delays in immunization programs. The vaccine requires cold chain logistics and must be stored at controlled temperatures, which poses distribution challenges in low-resource settings. Additionally, adverse reactions to the live-attenuated vaccine—though rare—can affect public perception and vaccination uptake. Regulatory hurdles and the long timeline for clinical trials and approval of newer formulations or alternatives also slow down market expansion, especially as newer manufacturers attempt to enter the space.

Emerging trends in the Yellow Fever Vaccines market include increased public-private partnerships to scale up vaccine production and improve distribution infrastructure. Technological advancements are pushing toward the development of thermostable formulations to overcome cold chain barriers. There is also rising investment in regional vaccine manufacturing hubs, particularly in Africa, to reduce reliance on global supply chains. Enhanced surveillance systems, digital vaccination records, and integration of yellow fever vaccines into routine immunization schedules are improving coverage rates. Moreover, the expansion of travel-related vaccine requirements and efforts to ensure universal access in endemic regions are expected to drive long-term market growth.

Global Yellow Fever Vaccines key players include Sanofi Pasteur, Bio-Manguinhos, FSUE Chumakov, etc. Global top three manufacturers hold a share about 90%. Middle East and Africa is the largest market, with a share about 70%, followed by South America, and Europe, both have a share about 30 percent. In terms of application, the largest application is Routine Immunization, followed by Travelers.

This report presents a comprehensive overview of the global Yellow Fever Vaccines market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Distribution Channel

• Institonal Contributions
• Private Purchase
• Others

Segment by Application

• Routine Immunization
• Travelers
• Other

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Yellow Fever Vaccines market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Routine Immunization, Travelers, Other evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact